Institute of Virology, Vaccines and Sera - Torlak, Vojvode Stepe 458, 11152 Belgrade, Serbia.
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Aug 1;879(23):2213-9. doi: 10.1016/j.jchromb.2011.06.003. Epub 2011 Jun 13.
Given an existing demand to establish a process of tetanus vaccine production in a way that allows its complete validation and standardization, this paper focuses on tetanus toxoid purification step. More precisely, we were looking at a possibility to replace the widely used ammonium-sulphate precipitation by a chromatographic method. Based on the tetanus toxin's biochemical characteristics, we have decided to examine the possibility of tetanus toxoid purification by hydrophobic chromatography, and by chromatographic techniques based on interaction with immobilized metal ions, i.e. chelating chromatography and immobilized metal affinity chromatography. We used samples obtained from differently fragmented crude tetanus toxins by formaldehyde treatment (assigned as TTd-A and TTd-B) as starting material for tetanus toxoid purification. Obtained results imply that purification of tetanus toxoid by hydrophobic chromatography represents a good alternative to ammonium-sulphate precipitation. Tetanus toxoid preparations obtained by hydrophobic chromatography were similar to those obtained by ammonium-sulphate precipitation in respect to yield, purity and immunogenicity. In addition, their immunogenicity was similar to standard tetanus toxoid preparation (NIBSC, Potters Bar, UK). Furthermore, the characteristics of crude tetanus toxin preparations had the lowest impact on the final purification product when hydrophobic chromatography was the applied method of tetanus toxoid purification. On the other hand, purifications of tetanus toxoid by chelating chromatography or immobilized metal affinity chromatography generally resulted in a very low yield due to not satisfactory tetanus toxoid binding to the column, and immunogenicity of the obtained tetanus toxoid-containing preparations was poor.
鉴于需要建立破伤风疫苗生产工艺,以实现完全验证和标准化,本文重点介绍破伤风类毒素的纯化步骤。更确切地说,我们正在研究用一种色谱方法替代广泛使用的硫酸铵沉淀的可能性。基于破伤风毒素的生化特性,我们决定研究通过疏水层析以及基于与固定化金属离子相互作用的层析技术(即螯合层析和固定化金属亲和层析)纯化破伤风类毒素的可能性。我们使用经甲醛处理的不同片段化粗破伤风毒素(分别命名为 TTd-A 和 TTd-B)作为起始材料来进行破伤风类毒素的纯化。获得的结果表明,用疏水层析法纯化破伤风类毒素是硫酸铵沉淀的一个很好的替代方法。用疏水层析法获得的破伤风类毒素制剂在产率、纯度和免疫原性方面与用硫酸铵沉淀法获得的制剂相似。此外,它们的免疫原性与标准破伤风类毒素制剂(英国国家生物标准与检定所,波特斯)相似。此外,当疏水层析法是破伤风类毒素纯化的应用方法时,粗破伤风毒素制剂的特性对最终纯化产物的影响最小。另一方面,由于破伤风类毒素与柱子的结合不理想,因此通过螯合层析或固定化金属亲和层析对破伤风类毒素进行的纯化通常导致产率非常低,并且获得的含破伤风类毒素的制剂的免疫原性很差。